Wolfe Absence May Have Disarming Effect On DXM Safety Panel

Industry stakeholders need not fear an attack from one of their most outspoken and unpredictable critics at the Sept. 14 advisory committee meeting to discuss the safety of the cough suppressant dextromethorphan